Biotech Millionaire

ABOUT THE NEWSLETTER

• Biotech Millionaire is a premium investment newsletter focused exclusively on high-upside, high-risk small-cap biotech stocks.

• The newsletter targets small-cap biotech stocks, particularly those with upcoming catalyst events like drug trial results or FDA decisions.

• Their unique C.A.S.H. investing formula (Catalyst, Addressable Market, Science, Hype Potential) ensures that only the most promising candidates make it into the Biotech Millionaire portfolio. 

• They also feature pre-revenue companies with promising pipeline candidates in clinical trials, with the goal for each portfolio stock to get at least a 100% return in the span of 12 to 24 months.

THE CASH SYSTEM

• C = Catalysts

Near-term events like clinical trials or FDA approvals

• A = Addressable Market

Size of the patient population

• S = Science

Strength and novelty of the biotechnological underpinnings

• H = Hype

Media and investor buzz that can spike stock prices

SUBSCRIPTION PRIVILEGES

• Model Portfolio Access. 

A live, curated portfolio of biotech recommendations that includes buy-to-price, target profit levels, risk commentary, and ongoing performance tracking.

• Real-Time Trade Alerts. 

Whenever the editors recommend buying, selling or trimming a position, subscribers get an instant alert via email.

• Monthly Deep-Dive Reports. 

Each month, subscribers receive a research-heavy issue spotlighting a new biotech opportunity. This is where the C.A.S.H. framework is applied in full detail.

• Weekly Updates & Market Commentary. 

Shorter, weekly briefings update you on the current status of portfolio stocks, new FDA/clinical announcements, and quick takes on hyped biotech names in the news.

• Special Reports Library. 

Access to archived special reports, which may include: Top Biotech Stocks, Emergency Biotech Watchlist, and sector-specific breakdowns.